Publications by authors named "Talia Golan"

Claim this Profile
E
Exploring pancreatic variability in BRCA carriers vs. Non-Carriers: A diffusion tensor MRI study.
Maria Raitses-Gurevich, Noam Tau, Efi Efraim Moss Massasa, Shimon Shahar, David Refaeli, Talia Golan

Eur J Radiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation.
Shira Sagie, Tomer Babu, Chen Weller, Claire Tabachnik, Ido Livneh, Talia Golan

Cell Rep Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Carcinoembryonic Antigen Levels Predict Failure to Reach Surgery in Patients with Borderline Resectable Pancreatic Cancer Referred to Neoadjuvant Therapy.
Arielle Jacover, Tamar Beller, Nedaa Mahamid, Noa Avishay, Karny Ilan, Talia Golan

Ann Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep phenotyping of health-disease continuum in the Human Phenotype Project.
Lee Reicher, Smadar Shilo, Anastasia Godneva, Guy Lutsker, Liron Zahavi, Talia Golan

Nat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.
Kevin J Harrington, Stephane Champiat, Joshua D Brody, Byoung Chul Cho, Emanuela Romano, Talia Golan

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Cancer with Liver Oligometastases-Different Patterns of Disease Progression May Suggest Benefits of Surgical Resection.
Nedaa Mahamid, Arielle Jacover, Angam Zabeda, Tamar Beller, Havi Murad, Talia Golan

J Clin Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, Zeynep Irem Ozay, Arshit Narang, Talia Golan

CA Cancer J Clin· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas.
Jason J Luke, Randy F Sweis, J Randolph Hecht, Reva Schneider, Mark N Stein, Talia Golan

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer.
Ariel Shimoni-Sebag, Ifat Abramovich, Bella Agranovich, Rami Massri, Chani Stossel, Talia Golan

Radiother Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors.
Toshio Shimizu, John Powderly, Albiruni Abdul Razak, Patricia LoRusso, Kathy D Miller, Talia Golan

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study.
Philip A Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi, Talia Golan

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors.
Toshio Shimizu, John Powderly, Albiruni Abdul Razak, Patricia LoRusso, Kathy D Miller, Talia Golan

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.
Danh-Tai Hoang, Gal Dinstag, Eldad D Shulman, Leandro C Hermida, Doreen S Ben-Zvi, Talia Golan

Nat Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage.
Johanna Zerbib, Marica Rosaria Ippolito, Yonatan Eliezer, Giuseppina De Feudis, Eli Reuveni, Talia Golan

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma.
Doron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, Orit Picard, Miri Yavzori, Talia Golan

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial.
Yaacov R Lawrence, Marcin Miszczyk, Laura A Dawson, Dayssy Alexandra Diaz Pardo, Artur Aguiar, Talia Golan

Lancet Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8 T cell activation and limit responsiveness to immunotherapy in mice.
Benjamin Assouline, Rachel Kahn, Lutfi Hodali, Reba Condiotti, Yarden Engel, Talia Golan

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
George Zogopoulos, Ido Haimi, Shenin A Sanoba, Jessica N Everett, Yifan Wang, Talia Golan

J Natl Compr Canc Netw· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
Ido Laish, Menachem Schechter, Alain Dancour, Sari Lieberman, Zohar Levi, Talia Golan

Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer.
Naama Halpern, Ben Boursi, Einat Shacham-Shmueli, Einav Nili Gal-Yam, Ofer Margalit, Talia Golan

Oncol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for the Management of Patients with Pancreatic Cancer with PARP Inhibitors.
Talia Golan, Maria Raitses-Gurevich, Tamar Beller, James Carroll, Jonathan R Brody

Cancer Treat Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival.
Ben Boursi, E Paul Wileyto, Ronac Mamtani, Susan M Domchek, Talia Golan

JAMA Netw Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic cancer outcome-local treatment with radiation using MRI-LINAC.
Galit Almog, Raphael M Pfeffer, Svetlana Zalmanov, Vladislav Grinberg, Yoav Lipsky, Talia Golan

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial.
E Gabriela Chiorean, Vincent Picozzi, Chung-Pin Li, Marc Peeters, Joan Maurel, Talia Golan

Cancer Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical evaluation of an organ culture system to predict patient response to cancer therapy.
Shay Golan, Vered Bar, Seth J Salpeter, Guy Neev, German Creiderman, Talia Golan

Front Med (Lausanne)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis